V. Buard

Nifurtimox-efl ornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis : a multicentre , randomised , phase III , non-inferiority trial

V. Kande, E. Torreele, M. Ilunga, 2009 .

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

Salah Ghabri, Els Torreele, Sara Ghorashian, 2009, The Lancet.

Characteristics, medical management and outcomes of survivors of sexual gender-based violence, Nairobi, Kenya.

A. Harries, R. Kosgei, R. Van den Bergh, 2013, Public health action.

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients

A. Lazzarin, A. Calmy, L. Galli, 2008, Antiviral therapy.